2Jacober SJ,Sowers JR.An update on perioperative management of diabetes.Arch Znter Med,1999,159:2405-2411.
3Holman RR,Cull CA,Turner RC.A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years(UKPDS Study 44).Diabetes Care,1999,22:960-964.
4Gill G.Ben bow S.Manging Surgery in the elderly diabetic patients.In Sinclair AJ Finucane P.eds.diabetes in old age[M].Second Edition Chichester:John Wiley＆Sons 2001.177-185.
5Leslie P,Plontnick Loretta M,Clark Frederick L,et al.Safety and effectiveness of insulin pump the rapy in children and adolescents with type 1 diabetes[J].Diabetes Care,2003,26:1142-1146.
7Li YB,Xu W,Liao ZH,et al.Induction of long-term glyeemic control in newly diagnosed type 2 diabetic patients is associated with improvement of β-cell function.Diabetes Care,2004,27:2597-2602.
8Ilkova H,Glaser B,Tunckale A,et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient inten-sive insulin treatment.Diabetes Care,1997,20:1353-1356.
9DeVries JH,Snoek FJ,Kostense PJ,et al.A randomized trial of continu-ous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.Diabetes Care,2002,25:2074-2080.
10BOLANDEA, GERYM, OSETERLEA, et al. continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia improvement abolic conerol, end enhence coping in adolescents with type Ⅰ diabetes. Diabetes Care 1999;22(11):1284-1289.
3Pires AC, Chacra AR. Insulin therapy for type I diabetes mellitus: past and present [J]. Arq Bras Endoerinol Metabol, 2008, 52 (2) : 268- 278.
4Aertgeerts K, Ye S, Tennant MG, et al. Crystal structure of human dipeptidyl peptidase IV in complex with a decapeptide reveals details on substrate specificity and tetrahedral intermediate formation [J]. Protein Sci, 2014, 13 (2): 412-421.
5Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of Type 2 Di- abetes mellitus by ehanges in lifestyle among subjeets with impaired glu- cose tolerance[J].N Engl J Med, 2011 : 1343-1349.
6Wendt TM, Tanji N, Guo J, et al. RAGE drives the development of glo- merulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy [J]. Am J Pathol, 2013, 162 (4) : 1123 -1128.
